Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temporo-masseteric Nerve Block (TMNB) in Healthy Volunteers
NCT05507164Phase 2Recruiting
- Sponsor
- Rutgers University
- Start
- Oct 2022
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in temporomandibular disorder (TMD), sponsored by Rutgers University. Started Oct 2022; status: recruiting.
02
Drugs
lidocaine
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on NCT05507164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507164.